System information

For cobas c 311/501 analyzers:

CRPHS: ACN 217

For cobas c 502 analyzer:

CRPHS: ACN 8217

Intended use

In vitro test for the quantitative determination of C‑reactive protein (CRP) in

human serum and plasma on Roche/Hitachi cobas c systems.

Measurement of CRP is of use for the detection and evaluation of

inflammatory disorders and associated diseases, infection and tissue injury.

Highly sensitive measurement of CRP may also be used as an aid in the

assessment of the risk of future coronary heart disease. When used as an

adjunct to other laboratory evaluation methods of acute coronary

syndromes, it may also be an additional independent indicator of recurrent

event prognosis in patients with stable coronary disease or acute coronary

syndrome.